SEC 13F Intelligence

Stephens Investment Management Group LLC / LGND

Stephens Investment Management Group LLC’s Ligand Pharmaceuticals Inc Position

Does Stephens Investment Management Group LLC own Ligand Pharmaceuticals Inc (LGND)? Yes — 494.7K shares worth $99M (+1.35% of its 13F portfolio) as of Q1 2026, down from 501.0K shares the prior filed quarter.

Position Value
$99M
Q1 2026
Shares
494.7K
% of Portfolio
+1.35%
Quarters Held
30
currently held

Position History LGND

Reported value by quarter
Q4 ’18: $55MQ4 ’18Q1 ’19: $54MQ2 ’19: $50MQ3 ’19: $51MQ4 ’19: $53MQ4 ’19Q1 ’20: $42MQ2 ’20: $70MQ3 ’20: $57MQ4 ’20: $58MQ4 ’20Q1 ’21: $57MQ2 ’21: $48MQ3 ’21: $57MQ4 ’21: $64MQ4 ’21Q1 ’22: $47MQ2 ’22: $40MQ3 ’22: $39MQ4 ’22: $31MQ4 ’22Q1 ’23: $33MQ2 ’23: $34MQ3 ’23: $28MQ4 ’23: $47MQ4 ’23Q1 ’24: $51MQ2 ’24: $55MQ3 ’24: $62MQ4 ’24: $66MQ4 ’24Q1 ’25: $64MQ2 ’25: $69MQ3 ’25: $98MQ4 ’25: $95MQ4 ’25Q1 ’26: $99Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026494.7K$99M+1.35%
Q4 2025501.0K$95M+1.23%
Q3 2025554.5K$98M+1.27%
Q2 2025604.8K$69M+0.91%
Q1 2025607.2K$64M+0.92%
Q4 2024612.8K$66M+0.88%
Q3 2024618.7K$62M+0.84%
Q2 2024652.0K$55M+0.77%
Q1 2024696.8K$51M+0.68%
Q4 2023659.4K$47M+0.69%
Q3 2023467.6K$28M+0.46%
Q2 2023466.4K$34M+0.52%
Q1 2023455.1K$33M+0.56%
Q4 2022454.4K$31M+0.56%
Q3 2022451.7K$39M+0.74%
Q2 2022453.6K$40M+0.75%
Q1 2022417.7K$47M+0.69%
Q4 2021411.4K$64M+0.82%
Q3 2021410.2K$57M+0.78%
Q2 2021363.4K$48M+0.65%
Q1 2021370.8K$57M+0.82%
Q4 2020582.3K$58M+0.86%
Q3 2020594.6K$57M+1.00%
Q2 2020623.9K$70M+1.26%
Q1 2020579.6K$42M+1.02%
Q4 2019508.1K$53M+1.00%
Q3 2019511.3K$51M+1.02%
Q2 2019442.2K$50M+0.96%
Q1 2019425.6K$54M+1.09%
Q4 2018408.3K$55M+1.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of LGND.